Skip to main content

Table 1 Characteristics of the patient populations used for the initial application of the self-efficacy instruments

From: Psychometric properties and performance of existing self-efficacy instruments in cancer populations: a systematic review

Instrument First author, year [reference number] Full name Country Sample size Cancer types Mean age (years) % female % high school or above Year since diagnosis(years) Treatment(stage& type)
SICPA Telch, 1986 [16] The Standford Inventory of Cancer Patient Adjustment USA 41 Mixed 18~65 NR NR NR NR
SUPPH Lev et,
1996 [13]
Strategies Used by People to Promote Health USA 178 Mixed 53.6 ± 13.55 61% 84% NR Chemo
SEAC Hirai, 2001 [26] The Self-Efficacy scale for Advanced Cancer Japan 50 Mixed terminal 60.8 ± 9.6 60% NR NR NR
SESCI Porter et al.,2002[15] Self-Efficacy for Symptom Control Inventory USA 30 Lung 62.5 ± 10.7 40% NR NR NR
CASE-cancer Wolf,2005 [20] The Communication and Attitudinal Self-Efficacy for cancer USA 136 Mixed 63.3 ± 15.0 15.2% 53.8% NR NR
OTSES-CA Liang,2008 [23] Opioid-Taking Self-Efficacy Scale-Cancer China 92 Mixed 56.4 ± 12.2 41% NR NR NR
CBI-B Heitzmann, 2011 [17] The brief version of Cancer Behavior Inventory USA 1304 Mixed 62 71% 41%~ 94% NR NR
PSEFSM Hofffman,2011
[18]
Perceived Self-Efficacy for Fatigue Self-Management instrument USA 298 Mixed Age ≥ 21 70% 90% NR Chemo +/− XRT
SESSM-B Lee,2012 [24] Self-Efficacy Scale for Self-Management of Breast cancer Korea 303 Breast 47.7 ± 8.7 100% 78.9% 3.4 ± 3.6 53.8% during tx
46.2% post tx
21.5% surgery,
27% XRT
52.8% chemo
3.7% hormone
BCSES Champion,2013 [25] Breast Cancer Survivor Self-efficacy Scale USA 1127 Breast 57.1 ± 11.6 100% 97% 5.9 ± 1.5 Post-chemo
C-SUPPH Yuan,2014 [14] Strategies Used by People to Promote Health-Chinese version China 764 Mixed 54.03 ± 5.13 50.8% NR NR 31% surgery + chemo
EBSES Buchan et al., 2015 [22] Exercise barriers self-efficacy scale Australia 101 Mixed 59.6/56.3 92.6%/
100%
NR NR NR
SMSES-BC Liang, 2015 [8] Symptom-management self-efficacy scale for breast cancer related to chemotherapy China 152 Breast 54.3 ± 9.9 100% 75.7% 4.2 ± 5.4 65.2% chemo
37.6% hormone
24.9% target
SMSFS-A Chan, 2016 [19] Self-efficacy in managing symptoms Scale-Fatigue Subscale for Patients With Advanced Cancer Australia 10 Mixed advanced cancer 62.6 ± 9.1 90% 70% NR 10% XRT
10% chemo+XRT
10% target
SESPRM-LC Huang et al., 2017 [21] Self-efficacy scale for rehabilitation management designed specifically for postoperative lung cancer patients China 448 Lung cancer 58.37 ± 9.9 39.6% 29.7% NR Surgery
  1. NR: not recorded, XRT radiation therapy